We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com. A fully percutaneous bypass system using the femoral ...
SUNNYVALE, Calif.--(BUSINESS WIRE)--Results from the DETOUR I Trial evaluating the PQ Bypass DETOUR System for percutaneous bypass showed promising 12-month durability for patients with extremely long ...
Please provide your email address to receive an email when new articles are posted on . Cardiva Medical announced its vascular closure system received an expanded indication in patients undergoing ...
“DETOUR is an innovative, yet intuitive endovascular procedure to create a bypass in a channel already provided by the body, but without performing open surgery,” said Jihad Mustapha, M.D., CEO of ...
LAS VEGAS, NV—An endovascular approach for the treatment of long, complex superficial femoropopliteal lesions that incorporates surgical principles results in good patency through 3 years with no late ...
A clinical study by Cardiva Medical evaluating its bioabsorbable vascular closure system for electrophysiology procedures met all of its primary and secondary endpoints compared to manual compression, ...
Approval of the Mynx Control Venous vascular closure device was based on results from the ReliaSeal trial, which demonstrated 100% procedural and device success in cardiac ablation procedures. The FDA ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results